Component 5, which described IL12R and IL2Rβ abundances, particularly in CD8+ cells, was also identified to have a unique relationship with BC status, in that BC patients featured either very positive or very negative component 5 scores (Fig. 4f). Here, CD8A is linked to breast cancer.